New hope for gout sufferers with kidney problems
NCT ID NCT04844814
Summary
This study aims to find a better way to treat sudden gout attacks in people with advanced kidney disease or kidney transplants. It compares two medications—anakinra and prednisone—to see which one reduces pain faster and with fewer side effects. The trial involves about 200 hospitalized patients who will receive one of the two treatments for up to five days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rhumathology department
Paris, Île-de-France Region, 75010, France
Conditions
Explore the condition pages connected to this study.